Interferon treatment of chronic active hepatitis C during therapy of acute lymphoblastic leukemia

American Journal of Hematology

Volumn 61, Issue 2, 1999, Pages 130-134

  Waldron, Peter ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acute lymphoblastic leukemia; Hepatitis C; Interferon

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; INTERFERON; MERCAPTOPURINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CHILD; CHRONIC ACTIVE HEPATITIS; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; TESTICULAR NEOPLASMS;

EID: 0032976903     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199906)61:2<130::AID-AJH10>3.0.CO;2-M     Document Type: Article

References (41)

1. Alter HJ. To C or not to C: these are the questions. Blood 1995;85: 1681-1695.
2. Aach RD. Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo G. Hepatitis C virus infection in post-transfusion hepatitis. N Engl J Med 1991;325:1325-1329.
3. Hetherington ML. Buchanan GR. Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions. Cancer 1988;62:1614-1618.
4. Myers B, Irving W, Hollingsworth R, Readett D, Lilleyman JS, Dolan G. Hepatitis C virus infection in multi-transfused children with haematological malignancy. Br J Haematol 1995;91:480-482.
5. Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, Mondelli MU. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994;84:2919-2922.
6. Locasciulli A, Cavalletto D, Pontisso P, Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 1993;82:2564-2567.
7. Dibenedetto SP, Ragusa R, Sciacca A, Di Cataldo A, Miraglia V, D'Amico S, Lo Nigro L, Ippolito AM. Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. Eur J Pediatr 1994;153:271-275.
8. Komatsu H, Fujisawa T, Inui A, Miyakawa Y, Onoue M, Sekine I, Hanada R, Yamamoto K. Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia. Blood 1996; 87:4072-4075.
9. Cetingul N, Kavakli K, Vergin C, Oztop S. Nisli G. Aydogdu S. Ozcar T. Bilgic A, Yuce G, Yagci R. Alpha-interferon-2b treatment for chronic hepatitis-B infection in children with cancer. J Trop Pediatr 1996;42:263-266.
10. Batts KP, Ludwig J. Chronic hepatitis: an update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
11. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti TJ, Crist WM. intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: a pediatric oncology group study. N Engl J Med 1986;315:273-278.
12. Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schrieber GB Ownby HE, Gilcher RO, Kleinman SH, Matijas L, Thomson RA, Nemo GJ. Demographic determinants of hepatitis C virus seroprevalence among blood donors. J Am Med Assoc 1996;275:995-1000.
13. Jonas MM. Robertson LM, Middleman AB. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr 1997;131:314-316.
14. Monteleone PM, Andrzejewski C, Kelleher JF. Prevalence of antibodies to hepatitis C virus in transfused children with cancer. Am J Pediatr Hematol Oncol 1994;16:309-313.
15. Cesaro S, Petris MG, Rossetti F, Cusinato R, Pipan C, Guido M, Masiero L, Botta GA, Meloni GA, Zanesco L. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997; 90:1315-1320.
16. Kanesaki T, Kinoshita S, Tsujino G, Yoshioka K, Ikegami N. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction. J Pediatr 1993;123:381-387.
17. Wagner N, Rotthauwe HW. Hepatitis C contributes to liver disease in children and adolescents with hemophilia. Klin Pädiatr 1994;206:40-44.
18. Hasan MF, Marsh F, Posner G, Bellevue R, Dosik H, Suatengco R, Ramani N. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol 1996;91:1204-1206.
19. Ni YH, Chang MH, Lin KH, Chen PJ, Lin DT, Hsu HY Chen DS. Hepatitis C viral infection in thalassemic children: Clinical and molecular studies. Pediatr Res 1996;39:323-328.
20. Angelucci E. Antibodies to hepatitis C virus in thalassemia. Haematologica 1994;79:353-355.
21. Jacyna MR, Brooks MG, Loke RH, Main J, Murray-Lyon IM, Thomas HC. Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A, non-B hepatitis. Br Med J 1989;298:80-82.
22. Schvarcz R, Weiland O, Wejslal R, Norkrans G, Fryden A, Foberg U. A randomised controlled open study of interferon alpha-2b treatment of chronic non-A, non-B post-transfusion hepatitis: no correlation of outcome to presence of hepatitis C virus antibodies. Scand J Infect Dis 1989; 21:617-625.
23. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996;24:778-789.
24. Powell DW. NIH Consensus Development Panel: management of hepatitis C. Hepatology 1997;26(Suppl 1):2S-9S.
25. Lindsay KL. Therapy of hepatitis C: overview. Hepatology 1997;26(3 Suppl 1):71S-77S.
26. Ruiz-Monero M, Rua MJ, Castillo I, Garcia-Novo MD, Santos M, Navas S, Carreno V. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study. Hepatology 1992;16: 882-885.
27. Matsuoka S, Mori K, Nakano O, Yuasa Y, Taguchi Y, Hayabuchi Y Kuroda Y. Efficacy of interferons in treating children with chronic hepatitis C. Eur J Pediatr 1997;156:704-708.
28. Bortolotti F, Giacchino R, Vajro P, Barbera C, Crivellaro C, Alberti A, Nebbia G, Zancan L, De Moliner L, Bertolini A, Balli F, Callea F. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995;22:1623-1627.
29. Marcellini M, Kondili L, Comparcola D, Spada E, Sartorelli, Palumbo M, Rapicetta M. High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease. Pediatr Infect Dis J 1997;16:1049-1053.
30. Iorio C, Pensati R, Porzio S, Fariello I, Guida S, Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child 1996;74:152-156.
31. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau MR, Faa G, Diana G, Dessi C, Melis A, Mazzoleni AP, Cornacchia G, Cao A, De Virgiliis. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr 1994;125:123-128.
32. Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, Maggio A, Fabiano C, Barbaria F, Craxi A. Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C. Blood 1997;90:2207-2212.
33. Fujisawa T, Inui A, Ohkawa T, Miyakawa Y, Onoue M, Sekine I, Hanada R, Yamamoto K. Response to interferon therapy in children with chronic hepatitis C. J Pediatr 1995;127:660-662.
34. Geissler RG, Ottman OG, Kojouharoff G, Reutzel P, Eder M, Hoelzer D, Ganser A. Influence of human recombinant interferon-alpha and interferon-gamma on bone marrow progenitor cells of HIV-positive individuals. AIDS Res Hum Retroviruses 1992;8:521-525.
35. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM. A comparison of three alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-1462.
36. Manabe A, Yi T, Kumagai M, Campana D. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. I. Cytotoxicity of interferon alpha in acute lymphoblastic leukemia. Leukemia 1993; 7:1990-1995.
37. Lauer SJ, Ochs J, Pollock BH, Buchanan GR. Recombinant alpha-2B interferon treatment for childhood lymphoblastic disease in relapse. A Pediatric Oncology Group phase II study. Cancer 1994;74:197-202.
38. Ochs J, Brecher ML, Mahoney D, Vega R, Pollock BH, Buchanan GR, Whitehead VM, Ravindranath Y, Freeman AI. Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study. J Clin Oncol 1991;9:777-782.
39. Pinkel D, Hernandez K, Borella L, Holton C, Aur R, Samoy G, Pratt C. Drug dose and remission duration in childhood lymphocytic leukemia. Cancer 1971;27:247-256.
40. Gobrecht O, Göbel U, Graubner U, Gutjahr P, Schock, V, Spaar HJ, Janka-Schaub GE. Influence of individual dose intensive therapy on prognosis in childhood acute lymphoblastic leukemia. Klin Pädiatr 1992;204:230-235.
41. Dibenedetto SP, Guardabasso V, Ragusa R, Di Cataldo A, Miraglia V, D'Amico S, Ippolito AM. 6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1994;11:251-258.